Inventor · disambiguated record
Jed Hubbs
Also filed as: HUBBS JED · HUBBS JED L · HUBBS JED LEE
10 granted patents·13 pending applications·9 citations·filing 2006–2024
81Inventor score
Top patents by PatentIndex Score
23 records- 0186US12134619B2Crystalline salts or co-crystals of 2′,6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with p-toluenesulofonic acid as GABAA positive allosteric modulatorsNEUROCYCLE THERAPEUTICS INC·Filed 2022·Granted Nov 5, 2024·2 cites·21 claims
- 0278US11542263B2Crystalline salts or co-crystals of 2′,6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b] [1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with phosphoric acid as GABAA positive allosteric modulatorsNEUROCYCLE THERAPEUTICS INC·Filed 2020·Granted Jan 3, 2023·1 cites·23 claims
- 0377US7772238B2Benzothiophene hydroxamic acid derivativesMERCK SHARP & DOHME·Filed 2006·Granted Aug 10, 2010·4 cites·15 claims
- 0472US2025034155A1CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-1-METHYLETHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-7-YL]BIPHENYL-2-CARBONITRILE WITH PHOSPHORIC ACID AS GABAA POSITIVE ALLOSTERIC MODULATORSNEUROCYCLE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0567US8168658B2Inhibitors of histone deacetylaseGRIMM JONATHAN B·Filed 2007·Granted May 1, 2012·2 cites·7 claims
- 0654US11571421B2GABAA positive allosteric modulator compounds for treatment of itch and/or dermatitisNEUROCYCLE THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·26 claims
- 0752US10273229B2N-substituted 4-aminoquinazoline derivatives and methods of useCODEXIS INC·Filed 2015·Granted Apr 30, 2019·0 cites·5 claims
- 0851US10045987B2Imidazoyl anilide derivatives and methods of useCODEXIS INC·Filed 2015·Granted Aug 14, 2018·0 cites·3 claims
- 0946US2023020036A1Treatment of epileptic conditions with gabaa receptor modulatorsNEUROCYCLE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1045US2010010041A1Difluorinated piperidines for treatment of alzheimer's disease and related conditionsSTANTON MATTHEW G·Filed 2007·Application pending·0 cites
- 1143US2022152037A1Use of gabaa receptor modulators for treatment of painNEUROCYCLE THERAPEUTIC INC·Filed 2020·Application pending·0 cites
- 1242US2023017378A1Gabaa positive allosteric modulator compounds, methods of making, and uses thereofNEUROCYCLE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1340US2013060022A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1440US2013060023A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1540US2013060021A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1640US2013060019A1Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates TheretoBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1740US2013060024A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1838US8420622B2Silylated piperidine derivativesMUNOZ BENITO·Filed 2007·Granted Apr 16, 2013·0 cites·9 claims
- 1937US8389547B2Piperidines and related compounds for the treatment of Alzheimer's diseaseGARCIA YUDITH·Filed 2007·Granted Mar 5, 2013·0 cites·11 claims
- 2037US2013060013A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2136US8609897B2Trifluoromethylsulfonamide gamma secretase inhibitorDANIELS MATTHEW·Filed 2010·Granted Dec 17, 2013·0 cites·8 claims
- 2235US2013060020A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2330US2011251379A1Compounds useful for treating neurodegenerative disordersSATORI PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jed Hubbs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →